We studied the capacity of multipotent mesenchymal stromal cells isolated from human bone marrow (BM) to long-term passaging, cloning, and re-cloning. Initial multipotent mesenchymal stromal cells and cells after gene labeling were studied. Multipotent mesenchymal stromal cells were obtained from donors (13–59 years) and cultured for 7 passages. Third generation lentivector was used for delivery of green fluorescent protein marker gene. The procedure of infection revealed reduced proliferative potential of multipotent mesenchymal stromal cells from elder donors. Hierarchy of precursor cells differing by their proliferative potential was demonstrated in the culture of multipotent mesenchymal stromal cells. Three categories of multipotent mesenchymal stromal cells were identified: mature cells incapable of proliferation (75.7 ± 2.4% population) and cells with low and high proliferative potential (17.6 ± 2.1 and 6.7 ± 0.3%, respectively). The relative content of these cells insignificantly differed from passage to passage. The efficiency of cloning also remains stable, but re-cloning capacity sharply decreased after passage 3 and completely disappeared in multipotent mesenchymal stromal cells after cryopreservation. Thus, cultured multipotent mesenchymal stromal cells represent a heterogeneous and hierarchically organized population and the characteristics of this population depend of the duration of culturing and age of BM donor. This should be taken into account when using multipotent mesenchymal stromal cells in clinical practice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
I. N. Nifontova, D. A. Svinareva, and N. I. Drize, Klet. Tekhnol. Biol. Med., No. 2, 115–120 (2008).
I. L. Chertkov, N. I. Drize, and A. I. Vorob’ev, Ter. Arkhiv, 78, No. 7, 5–12 (2006).
A. I. Caplan and S. P. Bruder, Trends Mol. Med., 7, No. 6, 259–264 (2001).
P. Chomczynski and N. Sacchi, Anal. Biochem., 162, No. 1, 156–159 (1987).
K. English, A. French, and K. J. Wood, Cell Stem Cell, 7, No. 4, 431–442 (2010).
E. M. Horwitz, K. Le Blanc, M. Dominici, et al., Cytotherapy, 7, No. 5, 393–395 (2005).
J. Justesen, K. Stenderup, E. F. Eriksen, and M. Kassem, Calcif. Tissue Int., 71, No. 1, 36–44 (2002).
C. C. Lee, J. E. Christensen, M. C. Yoder, and A. F. Tarantal, Exp. Hematol., 38, No. 1, 46–54 (2010).
S. R. Mayack, J. L. Shadrach, F. S. Kim, and A. J. Wagers, Nature, 463, No. 7280, 495–500 (2010).
K. Miyazono, Y. Kamiya, and M. Morikawa, J. Biochem., 147, No. 1, 35–51 (2010).
M. F. Pittenger, A. M. Mackay, S. C. Beck, et al., Science, 284, No. 5411, 143–147 (1999).
A. Stolzing, E. Jones, D. McGonagle, and A. Scutt, Mech. Ageing Dev., 129, No. 3, 163–173 (2008).
D. A. Svinareva, T. V. Petrova, I. N. Shipunova, et al., Ter. Arkh., 81, No. 7, 66–70 (2009).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Kletochnye Tekhnologii v Biologii i Meditsine, No. 4, pp. 230–234, December, 2011
Rights and permissions
About this article
Cite this article
Zhironkina, O.A., Shipounova, I.N., Bigildeev, A.E. et al. Proliferative Potential of Multipotent Mesenchymal Stromal Cells from Human Bone Marrow. Bull Exp Biol Med 152, 543–547 (2012). https://doi.org/10.1007/s10517-012-1571-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-012-1571-5